Ellen G Kline

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to Cefepime”.

Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to Cefepime

Clinical Infectious Diseases(2020)10.1093/cid/ciaa355

N/A

0.689DataRank · unranked

98 citations

Alina Iovleva, Ellen G Kline, Akito Kawai, Christi L. McElheny, Yohei Doi +1 more

Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac294

N/A

0.457DataRank · unranked

20 citations

Paul R. Merlau, Cole S Hudson, Ellen G Kline, Brianna M. Eales, James J. Smith +3 more

2185. In vitro activity of aztreonam-avibactam (ATM-AVI), cefiderocol (FDC), and cefepime-taniborbactam (FEP-TAN) against multi-species, NDM-producing Enterobacterales causing a local outbreak

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad500.1807

N/A

0.165DataRank · unranked

2 citations

Kevin M Squires, Ghady Haidar, Graham M. Snyder, Lee H. Harrison, Daria Van Tyne +2 more

Differential ampicillin/ceftriaxone susceptibility among diverse Enterococcus faecalis from infective endocarditis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.07.447474

N/A

0DataRank · unranked

0 citations

Gayatri Shankar Chilambi, Hayley R. Nordstrom, Alina Iovleva, Niyati H Shah, Chelsea E Jones +5 more

Evolution and Transmission of Cefiderocol-Resistant Acinetobacter baumannii During an Outbreak in the Burn Intensive Care Unit

Clinical Infectious Diseases(2022)10.1093/cid/ciac647

N/A

0DataRank · unranked

50 citations

Alison Brophy, Samuel Reveron, Alina Iovleva, Ellen G Kline, Michael A. Marano +3 more

Evolution of Imipenem-Relebactam Resistance Following Treatment of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia

Clinical Infectious Diseases(2022)10.1093/cid/ciac097

N/A

0DataRank · unranked

49 citations

Madison E. Stellfox, Ellen G Kline, Palash Samanta, Daria Van Tyne, Ryan K. Shields

Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans

Transplant Infectious Disease(2023)10.1111/tid.14041

N/A

0DataRank · unranked

40 citations

Benjamin K. Chan, Shu‐Ting Cho, Kailey Hughes Kramer, Hayley R. Nordstrom, Nathan R. Wallace +11 more

In vitro activity of cefiderocol against Pseudomonas aeruginosa demonstrating evolved resistance to novel β-lactam/β-lactamase inhibitors

JAC-Antimicrobial Resistance(2023)10.1093/jacamr/dlad107

N/A

0DataRank · unranked

39 citations

Ellen G Kline, Kevin M Squires, Daria Van Tyne, Yohei Doi, Ryan K. Shields

Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients

Journal of Antimicrobial Chemotherapy(2023)10.1093/jac/dkad042

N/A

0DataRank · unranked

22 citations

Kimberly C. Claeys, Ellen G Kline, Tara M Rogers, Kevin M Squires, Alina Iovleva +6 more

Impact ofompk36genotype and KPC subtype on thein vitroactivity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against KPC-producingK. pneumoniaeclinical isolates

JAC-Antimicrobial Resistance(2023)10.1093/jacamr/dlad022

N/A

0DataRank · unranked

16 citations

Ellen G Kline, M. Patrick Griffith, Chelsea E Jones, Abigail M Rubio, Kevin M Squires +2 more

Mutations in ompK36 differentially impact in vitro synergy of meropenem/vaborbactam and ceftazidime/avibactam in combination with other antibiotics against KPC-producing Klebsiella pneumoniae

JAC-Antimicrobial Resistance(2023)10.1093/jacamr/dlad113

N/A

0DataRank · unranked

10 citations

Ellen G Kline, M. Patrick Griffith, Chelsea E Jones, Abigail M Rubio, Kevin M Squires +2 more

60 Bacteriophage therapy for Pseudomonas aeruginosa infections in people with cystic fibrosis

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)00995-5

N/A

0DataRank · unranked

0 citations

N. Wallace, Hayley R. Nordstrom, Kathleen Squires, Ellen G Kline, Kailey Hughes Kramer +4 more

Frequency of cefiderocol heteroresistance among patients treated with cefiderocol for carbapenem-resistant Acinetobacter baumannii infections

JAC-Antimicrobial Resistance(2024)10.1093/jacamr/dlae146

N/A

0DataRank · unranked

31 citations

Ava J Dorazio, Giusy Tiseo, Kevin M Squires, Alessandro Leonildi, Cesira Giordano +8 more

Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia

Clinical Infectious Diseases(2024)10.1093/cid/ciae332

N/A

0DataRank · unranked

29 citations

Ellen G Kline, Ghady Haidar, Kevin M Squires, Jason M. Pogue, Erin K. McCreary +6 more

Emergence of high-level aztreonam–avibactam and cefiderocol resistance following treatment of an NDM-producing Escherichia coli bloodstream isolate exhibiting reduced susceptibility to both agents at baseline

JAC-Antimicrobial Resistance(2024)10.1093/jacamr/dlae141

N/A

0DataRank · unranked

27 citations

Ellen G Kline, Georgios D. Kitsios, Xiaohong Wang, E.J. Kwak, Anthony Newbrough +4 more

The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States—Is There a Potential Role for Durlobactam?

Clinical Infectious Diseases(2024)10.1093/cid/ciae229

N/A

0DataRank · unranked

20 citations

Virginia Pierce, Jason M. Pogue, Ellen G Kline, Frank Tverdek, Ryan K. Shields +1 more

Differential in vitro susceptibility to ampicillin/ceftriaxone combination therapy among Enterococcus faecalis infective endocarditis clinical isolates

Journal of Antimicrobial Chemotherapy(2024)10.1093/jac/dkae032

N/A

0DataRank · unranked

13 citations

Gayatri Shankar Chilambi, Madison E. Stellfox, Hayley R. Nordstrom, Yanhong Li, Alina Iovleva +11 more

Comparative in vitro activity of sulbactam with avibactam or durlobactam against carbapenem-resistant Acinetobacter baumannii

JAC-Antimicrobial Resistance(2025)10.1093/jacamr/dlaf098

N/A

0DataRank · unranked

4 citations

Ellen G Kline, Kevin M Squires, M. Patrick Griffith, Yohei Doi, Ryan K. Shields +1 more

Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in Enterobacter cloacae Due to AmpC R2 Loop Deletion

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.00198-20

N/A

0DataRank · unranked

84 citations

Christi L. McElheny, Alina Iovleva, Ellen G Kline, Nicolas Sluis‐Cremer, Ryan K. Shields +2 more

Molecular Epidemiology, Natural History, and Long-Term Outcomes of Multidrug-Resistant Enterobacterales Colonization and Infections Among Solid Organ Transplant Recipients

Clinical Infectious Diseases(2021)10.1093/cid/ciab427

N/A

0DataRank · unranked

42 citations

Ryan K. Shields, Liang Chen, A. William Pasculle, Binghua Hao, Shaoji Cheng +5 more